CareMetx Acquires Cencora’s U.S. Hub Consulting Services, Expanding Patient‑Access Platform

COR
April 27, 2026

CareMetx has acquired Cencora’s U.S. Hub consulting services operations, which include the TheraCom free‑goods pharmacy. The transaction adds full‑service hub operations, patient‑access staffing infrastructure, and free‑goods pharmacy fulfillment to CareMetx’s platform, broadening its ability to serve a larger portfolio of pharmaceutical brands and patient populations across pharmacy, medical, and dual‑benefit products.

Cencora is divesting non‑core consulting assets as part of a broader transformation toward high‑margin specialty services and oncology‑focused operations. By selling its U.S. Hub consulting services, Cencora can concentrate capital and resources on specialty‑services initiatives such as OneOncology and Retina Consultants of America, while maintaining a partnership with CareMetx for ongoing patient‑services delivery in the United States.

The acquisition strengthens CareMetx’s end‑to‑end patient‑access capabilities. Adding hub operations and staffing infrastructure enhances workflow automation and data analytics, which can reduce friction for manufacturers and improve patient outcomes. The free‑goods pharmacy component expands CareMetx’s reach to patients who qualify for medication assistance, reinforcing its value proposition to pharmaceutical clients.

Greg Morris, President and Chief Strategy Officer of CareMetx, said the acquisition reflects the company’s growth and the confidence its clients and partners place in its model. Bob Mauch, President and Chief Executive Officer of Cencora, highlighted the company’s focus on high‑margin specialty services and digital transformation. Jim Cleary, Executive Vice President and Chief Financial Officer of Cencora, noted that the acquisition aligns with the company’s strategic priorities and supports its specialty‑services transformation.

Investors view the deal as part of a series of moves by Cencora, including a $1.1 billion acquisition of Retina Consultants of America and a $1 billion investment in automation and cold‑chain expansion. The divestiture of legacy hub services is seen as a step toward higher margins and a clearer focus on specialty services, while the continued partnership with CareMetx provides continuity for patient‑services delivery.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.